Salus University, Elkins Park, Pennsylvania, USA.
College of Optometry, The Ohio State University, Columbus, Ohio, USA.
Cochrane Database Syst Rev. 2020 Dec 2;12(12):CD006768. doi: 10.1002/14651858.CD006768.pub3.
Convergence insufficiency is a common binocular vision disorder in which the eyes have a strong tendency to drift outward (exophoria) with difficulty turning the eyes inward when reading or doing close work.
To assess the comparative effectiveness and relative ranking of non-surgical interventions for convergence insufficiency through a systematic review and network meta-analysis (NMA).
We searched CENTRAL, MEDLINE, Embase, PubMed and three trials registers up to 20 September 2019.
We included randomized controlled trials (RCTs) examining any form of non-surgical intervention versus placebo, no treatment, sham treatment, or other non-surgical interventions. Participants were children and adults with symptomatic convergence insufficiency.
We followed standard Cochrane methodology. We performed NMAs separately for children and adults.
We included 12 trials (six in children and six in adults) with a total of 1289 participants. Trials evaluated seven interventions: 1) office-based vergence/accommodative therapy with home reinforcement; 2) home-based pencil/target push-ups; 3) home-based computer vergence/accommodative therapy; 4) office-based vergence/accommodative therapy alone; 5) placebo vergence/accommodative therapy or other placebo intervention; 6) prism reading glasses; and 7) placebo reading glasses. Six RCTs in the pediatric population randomized 968 participants. Of these, the Convergence Insufficiency Treatment Trial (CITT) Investigator Group completed four RCTs with 737 participants. All four CITT RCTs were rated at low risk of bias. Diagnostic criteria and outcome measures were identical or similar among these trials. The four CITT RCTs contributed data to the pediatric NMA, incorporating interventions 1, 2, 3 and 5. When treatment success was defined by a composite outcome requiring both clinical measures of convergence to be normal, and also show a pre-specified magnitude of improvement, we found high-certainty evidence that office-based vergence/accommodative therapy with home reinforcement increases the chance of a successful outcome, compared with home-based computer vergence/accommodative therapy (risk ratio (RR) 1.96, 95% confidence interval (CI) 1.32 to 2.94), home-based pencil/target push-ups (RR 2.86, 95% CI 1.82 to 4.35); and placebo (RR 3.04, 95% CI 2.32 to 3.98). However, there may be no evidence of any treatment difference between home-based computer vergence/accommodative therapy and home-based pencil/target push-ups (RR 1.44, 95% CI 0.93 to 2.24; low-certainty evidence), or between either of the two home-based therapies and placebo therapy, for the outcome of treatment success. When treatment success was defined as the composite convergence and symptom success outcome, we found moderate-certainty evidence that participants who received office-based vergence/accommodative therapy with home reinforcement were 5.12 (95% CI 2.01 to 13.07) times more likely to achieve treatment success than those who received placebo therapy. We found low-certainty evidence that participants who received office-based vergence/accommodative therapy with home reinforcement might be 4.41 (95% CI 1.26 to 15.38) times more likely to achieve treatment success than those who received home-based pencil push-ups, and 4.65 (95% CI 1.23 to 17.54) times more likely than those who received home-based computer vergence/accommodative therapy. There was no evidence of any treatment difference between home-based pencil push-ups and home-based computer vergence/accommodative therapy, or between either of the two home-based therapies and placebo therapy. One RCT evaluated the effectiveness of base-in prism reading glasses in children. When base-in prism reading glasses were compared with placebo reading glasses, investigators found no evidence of a difference in the three outcome measures of near point convergence (NPC), positive fusional vergence (PFV), or symptom scores measured by the Convergence Insufficiency Symptom Survey (CISS). Six RCTs in the adult population randomized 321 participants. We rated only one RCT at low risk of bias. Because not all studies of adults included composite success data, we could not conduct NMAs for treatment success. We thus were limited to comparing the mean difference (MD) between interventions for improving NPC, PFV, and CISS scores individually using data from three RCTs (107 participants; interventions 1, 2, 4 and 5). Compared with placebo treatment, office-based vergence accommodative therapy was relatively more effective in improving PFV (MD 16.73, 95% CI 6.96 to 26.60), but there was no evidence of a difference for NPC or the CISS score. There was no evidence of difference for any other comparisons for any outcomes. One trial evaluated base-in prism glasses prescribed for near-work activities and found that the prism glasses group had fewer symptoms compared with the placebo glasses group at three months (MD -8.9, 95% CI -11.6 to -6.3). The trial found no evidence of a difference with this intervention in NPC or PFV. No adverse effects related to study treatments were reported for any of the included studies. Excellent adherence was reported for office-based vergence/accommodative therapy (96.6% or higher) in two trials. Reported adherence with home-based therapy was less consistent, with one study reporting decreasing adherence over time (weeks 7 to 12) and lower completion rates with home-based pencil/target push-ups.
AUTHORS' CONCLUSIONS: Current research suggests that office-based vergence/accommodative therapy with home reinforcement is more effective than home-based pencil/target push-ups or home-based computer vergence/accommodative therapy for children. In adults, evidence of the effectiveness of various non-surgical interventions is less clear.
集合不足是一种常见的双眼视觉障碍,其特征是眼睛在阅读或进行近距离工作时向外漂移(外斜视)的趋势很强,难以向内转动眼睛。
通过系统评价和网络荟萃分析(NMA)评估集合不足的非手术干预措施的相对有效性和相对排名。
我们检索了 CENTRAL、MEDLINE、Embase、PubMed 和三个试验注册库,截至 2019 年 9 月 20 日。
我们纳入了任何形式的非手术干预与安慰剂、无治疗、假治疗或其他非手术干预比较的随机对照试验(RCT)。参与者为有症状的集合不足的儿童和成年人。
我们遵循了标准的 Cochrane 方法。我们分别对儿童和成人进行了 NMA。
我们纳入了 12 项试验(儿童 6 项,成人 6 项),共计 1289 名参与者。试验评估了七种干预措施:1)办公室基础的集合调节治疗,家庭强化;2)家庭基础的铅笔/目标推球;3)家庭基础的计算机集合调节治疗;4)办公室基础的集合调节治疗单独进行;5)安慰剂集合调节治疗或其他安慰剂干预;6)棱镜阅读眼镜;7)安慰剂阅读眼镜。儿科人群中的 6 项 RCT 随机分配了 968 名参与者。其中,集合不足治疗试验(CITT)调查员小组完成了四项有 737 名参与者的 RCT。四项 CITT RCT 均被评为低偏倚风险。这些试验中的诊断标准和结局测量是相同或相似的。四项 CITT RCT 提供的数据均纳入了儿科 NMA,包括干预措施 1、2、3 和 5。当治疗成功定义为需要同时满足临床集合测量正常和预先指定的改善程度的复合结局时,我们发现,与家庭基础的计算机集合调节治疗相比,办公室基础的集合调节治疗与家庭强化(风险比(RR)1.96,95%置信区间(CI)1.32 至 2.94),家庭基础的铅笔/目标推球(RR 2.86,95%CI 1.82 至 4.35);与安慰剂(RR 3.04,95%CI 2.32 至 3.98)相比,更有可能取得成功。然而,家庭基础的计算机集合调节治疗与家庭基础的铅笔/目标推球之间(RR 1.44,95%CI 0.93 至 2.24;低确定性证据),或者任何两种家庭治疗与安慰剂治疗之间(RR 1.44,95%CI 0.93 至 2.24;低确定性证据),可能都没有证据表明存在任何治疗差异,对于治疗成功的结局。当治疗成功定义为复合集合和症状成功结局时,我们发现,与接受安慰剂治疗的参与者相比,接受办公室基础的集合调节治疗与家庭强化的参与者有 5.12(95%CI 2.01 至 13.07)倍的可能性实现治疗成功。我们发现,与接受家庭基础的铅笔推球治疗的参与者相比,接受办公室基础的集合调节治疗与家庭强化的参与者可能有 4.41(95%CI 1.26 至 15.38)倍的可能性实现治疗成功,与接受家庭基础的计算机集合调节治疗的参与者相比,可能性有 4.65(95%CI 1.23 至 17.54)倍。家庭基础的铅笔推球和家庭基础的计算机集合调节治疗之间,或者任何两种家庭治疗与安慰剂治疗之间,都没有证据表明存在任何治疗差异。一项 RCT 评估了基底向内棱镜阅读眼镜在儿童中的有效性。当基底向内棱镜阅读眼镜与安慰剂阅读眼镜相比时,研究人员发现,在近点集合(NPC)、正融合性集合(PFV)或使用集合不足症状调查(CISS)测量的症状评分这三个结局测量中,没有证据表明两者存在差异。在成人人群中的 6 项 RCT 随机分配了 321 名参与者。我们仅对一项 RCT 评为低偏倚风险。由于并非所有成人研究都包含复合成功数据,因此我们无法对治疗成功进行 NMA。因此,我们只能使用来自三项 RCT(107 名参与者;干预措施 1、2、4 和 5)的数据,比较改善 NPC、PFV 和 CISS 评分的干预措施之间的平均差异(MD)。与安慰剂治疗相比,办公室基础的集合调节治疗在改善 PFV 方面更为有效(MD 16.73,95%CI 6.96 至 26.60),但在 NPC 或 CISS 评分方面没有证据表明存在差异。对于任何其他结局,都没有证据表明存在差异。一项试验评估了基底向内棱镜眼镜在近距工作活动中的应用,发现棱镜眼镜组在三个月时的症状比安慰剂眼镜组少(MD-8.9,95%CI-11.6 至-6.3)。该试验发现,与该干预措施相比,在 NPC 或 PFV 方面没有差异。没有任何研究报告与研究治疗相关的不良影响。两项试验报告了办公室基础的集合调节治疗的高依从性(96.6%或更高)。家庭治疗的报告依从性不太一致,一项研究报告称随着时间的推移(第 7 周到第 12 周)依从性下降,家庭基础的铅笔/目标推球完成率较低。
目前的研究表明,与家庭基础的铅笔/目标推球或家庭基础的计算机集合调节治疗相比,办公室基础的集合调节治疗与家庭强化对儿童更有效。在成人中,各种非手术干预措施的有效性证据不太明确。